Ipca Laboratories

Ipca Laboratories

Type	Public company
Traded as	BSE: 524494 NSE: IPCALAB
Industry	Pharmaceutical
Founded	19 October 1949 (Mumbai)
Founder	K.B. Mehla Dr. N.S. Tibrawala
Headquarters	Mumbai, India[1]
Area served	Worldwide
Key people	Prem Chand Godha, MD,[2] Mr. AK Jain, JMD[3]
Products	Pharmaceuticals, drugs
Revenue	15.59 billion (US$250 million)[4]
Number of employees	8,001 (2011)
Subsidiaries	CCPL Software,[2] Ipca Traditional Remedies[5]
Website	www.ipcalabs.com

Ipca Laboratories is an international pharmaceutical company based in Mumbai, India. It is also one of the largest suppliers of these APIs and their intermediates world over.^[6] It produces more than 150 formulations that include oral liquids, tablets, dry powders, and capsules.^[7] The various kinds of drug intermediates that the company manufactures include Theo bromine, Acetylthiophene, and P- Bromo Toluene and promotes over 36 countries of Asia, Africa, CIS, and South America, including Cambodia, Kazakhstan, Kenya, Mauritius, Myanmar, Nigeria, Oman, Russia, Sri Lanka, Sudan, Tanzania, Ukraine, Vietnam and Yemen. The main activities of company are to produce and market pharmaceuticals and drugs. The various products of the company include formulations, drug intermediates, and active pharmaceutical ingredients (API).

In 2004, Forbes selected Ipca, for the second consecutive year as one among the first 200 'Best under a Billion Company' in Asia.^[8]

It also got certification from US Food and Drug Administration (FDA), UK-Medicines and Healthcare products Regulatory Agency (MHRA), South Africa-Medicines Control Council (MCC), Brazil-Brazilian National Health Vigilance Agency (ANVISA) and Australia-Therapeutic Goods Administration (TGA).

History

It was founded by group of businessmen and medical professionals in 1949.^[9] In 1975, the management of the company was taken over by Amitabh Bachchan, Ajitabh Bachchan, Jaya Bachchan, M.R. Chandurkar, P.C. Godha.^[8]

References